Jefferies says Regeneron’s Dupixent drug could drive shares 15% higher
Regeneron's Dupixent drug could serve as the next big catalyst for shares of the pharmaceutical company, according to Jefferies.
Source link
- Russia forces may go to Ukraine’s Kyiv or Lviv cities: Official
- Pragma Bio is searching for cancer treatments hidden in our microbiome
